Suboptimal facial expression primes in textual media messages: Evidence for the affective congruency effect
Original Research Article- Pages 64-77
Abstract
The effectiveness of suboptimal affective primes in real media applications has remained debatable. We investigated the effects of suboptimally (at 10-ms exposure) presented facial expression primes on emotional responses to, and cognitive evaluations of, textual (business news) messages ranging from slightly unpleasant to slightly pleasant among 33 participants. Facial expression primes were presented repeatedly on a simulated small screen of a mobile device during a news reading task. Facial electromyography (EMG) recordings were used as physiological indices of positive and negative emotions. Our results showed affective congruency effects between news messages and facial expression primes: joyful facial expressions, compared to angry primes or no priming, elicited higher positive affect evaluations and more positive facial EMG responses, as well as higher interest, when embedded in affectively more positive news. On the other hand, the mere presence of suboptimal primes was detrimental to the perceived trustworthiness of news. These results suggest that embedding suboptimal facial expression primes into textual media messages may exert an influence on affectively congruent messages; at the same time, our results highlight the potential hazards and difficulties of utilizing such primes.
Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease
- Anne M. Fagan, et. al.
- ↵*Corresponding author. E-mail: fagana@neuro.wustl.edu
Abstract
Clinicopathological evidence suggests that the pathology of Alzheimer’s disease (AD) begins many years before the appearance of cognitive symptoms. Biomarkers are required to identify affected individuals during this asymptomatic (“preclinical”) stage to permit intervention with potential disease-modifying therapies designed to preserve normal brain function. Studies of families with autosomal-dominant AD (ADAD) mutations provide a unique and powerful means to investigate AD biomarker changes during the asymptomatic period. In this biomarker study, we collected cerebrospinal fluid (CSF), plasma, and in vivo amyloid imaging cross-sectional data at baseline in individuals from ADAD families enrolled in the Dominantly Inherited Alzheimer Network. Our study revealed reduced concentrations of CSF amyloid-β1–42 (Aβ1–42) associated with the presence of Aβ plaques, and elevated concentrations of CSF tau, ptau181 (phosphorylated tau181), and VILIP-1 (visinin-like protein-1), markers of neurofibrillary tangles and neuronal injury/death, in asymptomatic mutation carriers 10 to 20 years before their estimated age at symptom onset (EAO) and before the detection of cognitive deficits. When compared longitudinally, however, the concentrations of CSF biomarkers of neuronal injury/death within individuals decreased after their EAO, suggesting a slowing of acute neurodegenerative processes with symptomatic disease progression. These results emphasize the importance of longitudinal, within-person assessment when modeling biomarker trajectories across the course of the disease. If corroborated, this pattern may influence the definition of a positive neurodegenerative biomarker outcome in clinical trials.
- Copyright © 2014, American Association for the Advancement of Science